The route the meningitis took decides how much cochlea is left

Design

quantitative histopathological study of archival human temporal bones with age-matched controls, University of Minnesota collection

Population

36 temporal bones from cases of otogenic or meningogenic meningitis with histological labyrinthitis, plus controls without ear or CNS disease

Primary outcome

outer and inner hair cell loss, spiral ganglion neuron and Scarpa's ganglion neuron counts

Effect

outer hair cell loss worse in otogenic (p = 0.01); inner hair cell loss only in otogenic (p = 0.019 vs meningogenic); spiral and Scarpa's ganglion loss equal between routes (p = 0.993 and 0.762)

Deafness after meningitis is a standing indication for early cochlear implantation, driven by the fear of cochlear ossification. This histopathological study asked a different question: how much of the sensory apparatus actually survives, and does it depend on how the infection reached the ear. Thirty-six archival human temporal bones from the University of Minnesota collection, all with a meningitis history and histological labyrinthitis, were grouped by route — otogenic or meningogenic — and compared with age-matched controls.

Outer hair cell loss occurred in both groups against controls, and was significantly worse in the otogenic group (p = 0.01). Inner hair cell loss was the discriminating finding: present only after otogenic infection (p = 0.019 versus meningogenic, p < 0.001 versus controls), with no difference between the meningogenic group and controls (p = 0.382). Spiral ganglion and Scarpa's ganglion neurons were reduced in both meningitis groups, with no difference between routes (p = 0.993 and 0.762).

That combination is what makes it interesting. Spiral ganglion neuron survival is the substrate a cochlear implant depends on, and it was equally damaged whichever route the infection took — so this does not predict implant outcome directly. What differs is hair cell survival, which matters for any residual natural hearing. An ear deafened by otogenic infection has lost more of its own hearing apparatus and has less to preserve. This is a small temporal bone series with no level of evidence assigned, no clinical outcomes, and specimens accumulated over decades of differing antibiotic practice — it is mechanistic evidence, and should not on its own change implantation timing.

• Distinguish otogenic from meningogenic meningitis when assessing an ear after post-meningitic deafness
• Expect less residual hair cell function after an otogenic route, and counsel hearing preservation accordingly
• Do not infer implant performance from this — spiral ganglion loss was equal between routes
• Vestibular ganglion loss occurred in both groups; assess balance as well as hearing
• Archival temporal bone specimens with no clinical outcomes: mechanistic evidence, not a basis for changing timing

The statistics, in plain English

With 36 temporal bones split across three groups, each comparison rests on roughly a dozen specimens, so a P value of 0.01 tells you the difference is unlikely to be chance without telling you it is large or representative. The null results for spiral ganglion and Scarpa's ganglion neurons (p = 0.993 and 0.762) are strikingly non-significant, but a study this small cannot exclude a moderate real difference — absence of evidence, not evidence of absence. Archival collections also select for people who came to autopsy at a specialist centre, which is not the same as the population presenting with post-meningitic deafness today.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.